Summary
General anaesthesia is the reversible depression of central nervous system function. There is still no agreement over what constitutes depth of anaesthesia, and the clinical anaesthetist must thus titrate drug input according to clinical signs (heart rate, blood pressure, somatic movement, autonomic responses).
The potency of inhalational agents may be expressed in terms of the MAC (minimum alveolar concentration); comparable end-points (including blood concentrations) have been proposed for the intravenous agents. Kinetic infusion regimens can be constructed for the intravenous agents to achieve the ED95 concentrations required to provide clinically adequate anaesthesia. However, because of individual differences in drug kinetics and: dynamics, as well as the influences of disease states and intercurrent therapy, the clinician will titrate the dose according to response. Administration of volatile or intravenous anaesthetics by fixed regimens may result in either overdosage or the risk of patient awareness.
The choice of anaesthetic drug is usually based on the nonhypnotic side effects of the different agents — including their central and regional cardiovascular effects, the speed and completeness of recovery, and the need to provide intraoperative analgesia. In addition, special techniques and drugs are often needed for neurosurgical, cardiothoracic and obstetric anaesthesia.
All anaesthetic agents (inhalation and intravenous) have other side effects (such as cardio-respiratory depression and organ toxicity related to the liver or kidney). Both halothane and enflurane may be responsible for postoperative hepatic dysfunction, while the metabolism of enflurane can also result in nephrotoxicity in patients with pre-existing renal dysfunction. Isoflurane has been reported to cause ‘coronary steal’ in patients with ischaemic heart disease through its coronary vasodilator properties.
Of the intravenous agents available for maintenance anaesthesia, large doses of thiopental result in prolonged recovery time, while ketamine may cause hallucinations. Benzodiazepines obtund these effects of ketamine, but are also accompanied by delayed recovery. At present, the combination of propofol and alfentanil offers the best pharmacological properties for maintenance of anaesthesia; however, caution is needed in the patient with ischaemic heart disease, hypertension or hypovolaemia.
Similar content being viewed by others
References
Ausems ME, Hug Jr CC, de Lange S. Variable rate infusion of alfentanil as a supplement to nitrous oxide anesthesia for general surgery. Anesthesia and Analgesia 62: 982–986, 1983
Ausems ME, Hug Jr CC, Stanski DR, Burm AGL. Plasma concentrations of alfentanil requirement to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 65: 362–373, 1986
Battito MF, Langner R, Bradley EL. Desflurane (I-653) and isoflurane in surgical patients; comparative hemodynamics and emergence. Abstract. Anesthesiology 73: A393, 1990
Becker LD, Paulson BA, Miller RD, Severinghaus JW, Eger EI. Biphasic respiratory depression after fentanyl-droperidol or fentanyl alone used to supplement nitrous oxide anesthesia. Anesthesiology 44: 291–296, 1976
Bland JHL, Lowenstein E. Halothane-induced decrease in experimental myocardial ischemia in the non-failing canine heart. Anesthesiology 45: 287–293, 1976
Brogden RL, Goa KL. Flumazenil: a preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use. Drugs 35: 448–467, 1988
Calverley RK, Smith NT, Jones CW, Prys-Roberts C, Eger EI. Ventilatory and cardiovascular effects of enflurane anesthesia during spontaneous ventilation in man. Anesthesia and Analgesia: Current Researches 57: 610–618, 1978b
Calverley RK, Smith NT, Prys-Roberts C, Eger EI, Jones CW. Cardiovascular effects of enflurane anesthesia during controlled ventilation in man. Anesthesia and Analgesia: Current Researches 57: 619–628, 1978a
Carter JA, Clarke TNS, Prys-Roberts C, Spelina KR. Restoration of baroreflex control of heart rate during recovery from anaesthesia. British Journal of Anaesthesia 58: 415–421, 1986
Choi SD, Spaulding BC, Gross JB, Apfelbaum JL. Comparison of the ventilatory effects of etomidate and methohexital. Anesthesiology 62: 442–447, 1985
Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics and analgesic activity of ketamine in humans. Journal of Pharmaceutical Sciences 71: 539–542, 1982
Coates DP, Monk CR, Prys-Roberts C, Turtle M. Hemodynamic effects of infusions of the emulsion formulation of propofol during nitrous oxide anesthesia in humans. Anesthesia and Analgesia 66: 64–70, 1987
Craig J, Cooper GM, Sear JW. Recovery from day-case anaesthesia. Comparison between methohexitone, Althesin and etomidate. British Journal of Anaesthesia 54: 447–451, 1982
Cullen PM, Turtle M, Prys-Roberts C, Way WL, Dye J. Effect of propofol anesthesia on baroreflex activity in humans. Anesthesia and Analgesia 66; 1115–1120, 1987
Delaney TJ, Kistner JR, Lake CL, Miller ED. Myocardial function during halothane and enflurane anesthesia in patients with coronary artery disease. Anesthesia and Analgesia: Current Researches 59: 240–244, 1980
Doze VA, Shafer A, White PF. Propofol-nitrous oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia. Anesthesiology 69: 63–71, 1988
Doze VA, Westphal LM, White PF. Comparison of propofol with methohexital for outpatient anesthesia. Anesthesia and Analgesia 65: 1189–1195, 1986
Dundee JW. Editorial: fifty years of thiopentone. British Journal of Anaesthesia 56: 211–213, 1984
Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam: a review of its pharmacological properties and therapeutic use. Drugs 28: 519–543, 1984
Eger II EI. Isoflurane: a review. Anesthesiology 55: 539–576, 1981
Eger II EI (Ed). Nitrous oxide, Elsevier, New York, 1985
Eger II EI, Johnson BH. Rates of awakening from anesthesia with I-653, halothane, isoflurane and sevoflurane: a test of the effect of anesthetic concentration and duration in rats. Anesthesia and Analgesia 66: 977–982, 1987
Fragen RJ, Shanks CA, Molteni A, Avram MJ. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology 61: 652–656, 1984
Fragen RJ, Weiss HW, Molteni A. The effect of propofol on adrenocortical steroidogenesis: a comparative study with etomidate and thiopental. Anesthesiology 66: 839–842, 1987
Gauss A, Henrich H, Wilder-Smith OHG. Echocardiographic assessment of the haemodynamic effects of propofol: a comparison with etomidate and thiopentone. Anaesthesia 46: 99–105, 1991
Ghouri AF, Bodner M, White PF. Recovery profile after desflurane-nitrous oxide versus isoflurane — nitrous oxide in outpatients. Anesthesiology 74: 419–424, 1991
Giese JL, Stockham RJ, Stanley TH, Pace NL, Nelissen RH. Etomidate versus thiopental for induction of anesthesia. Anesthesia and Analgesia 64: 871–876, 1985
Gold MI, Sacks DJ, Grosnoff DB, Herrington CA. Comparison of propofol with thiopental and isoflurane for induction and maintenance of general anesthesia. Journal of Clinical Anesthesia 1: 272–276, 1989
Grant IS, Nimmo WS, Clements JA. Pharmacokinetics and analgesic effects of im and oral ketamine. British Journal of Anaesthesia 53: 805–810, 1981
Harris CE, Murray AM, Anderson JM, Grounds RM, Morgan M. Effects of thiopentone, etomidate and propofol on the haemodynamic response to tracheal intubation. Anaesthesia 43 (Suppl.): 32–36, 1988
Heath PJ, Kennedy DJ, Ogg TW, Gilks WR. Which intravenous agent for day surgery? A comparison of propofol, thiopentone, methohexitone and etomidate. Anaesthesia 43: 365–368, 1988
Heath PJ, Ogg TW, Gilks WR. Recovery after day-case anaesthesia: a 24-hour comparison of recovery after thiopentone or propofol anaesthesia. Anaesthesia 45; 911–915, 1990
Heijke S, Smith G. Quest for the ideal inhalation anaesthetic agent. British Journal of Anaesthesia 64: 3–6, 1990
Hickey R, Sybert P, Verrier E, Cason B. Effects of halothane, enflurane and isoflurane on coronary blood flow autoregulation and coronary vascular reserve in the canine heart. Anesthesiology 68: 21–30, 1988
Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 54: 100–106, 1981
Holmes MA, Weiskopf RB, Eger II EI, Johnson BH, Rampil IJ. Hepatocellular integrity in swine after prolonged desflurane (I-653) and isoflurane anesthesia: evaluation of plasma alanine aminotransferase activity. Anesthesia and Analgesia 71: 249–253, 1990
Horan BF, Prys-Roberts C, Hamilton WK, Roberts JG. Haemodynamic responses to enflurane anaesthesia and hypovolaemia in the dog, and their modification by propranolol. British Journal of Anaesthesia 49: 1189–1197, 1977
Idvall J, Ahlgren I, Aronsen KF, Stenberg P. Ketamine infusions: pharmacokinetics and clinical effects. British Journal of Anaesthesia 51: 1167–1173, 1979
Jones JG, Konieczko K. Hearing and memory in anaesthetized patients. British Medical Journal 292: 1291–1293, 1986
Jones RM, Cashman JN, Mant TGK. Clinical impressions and cardiorespiratory effects of a new fluorinated inhalation anaesthetic, desflurane (I-653), in volunteers. British Journal of Anaesthesia 64: 11–15, 1990
Kazama T, Ikeda K. Comparative cardiovascular effects of sevoflurane with halothane and isoflurane. Journal of Anesthesia 2: 63–68, 1988
Kestin IC, Harvey PB, Nixon C. Psychomotor recovery after three methods of sedation during spinal anaesthesia. British Journal of Anaesthesia 64: 675–681, 1990
Koblin DD, Weiskopf RB, Holmes MA, Konopka K, Rampil IJ, et al. Metabolism of desflurane and isoflurane in swine. Anesthesia and Analgesia 68: 147–149, 1989
Korttila K, Ostman PL, Faure E, Apfelbaum JL, Ekdawi M, et al. Randomized comparison of outcome after propofol-nitrous oxide or enflurane-nitrous oxide anaesthesia in operations of long duration. Canadian Journal of Anaesthesia 36: 651–657, 1989
Korttila K, Ostman PL, Faure E, Apfelbaum JL, Prunskis J, et al. Randomized comparison of recovery after propofol-nitrous oxide versus thiopentone-isoflurane-nitrous oxide anaesthesia in patients undergoing ambulatory surgery. Acta Anaesthesiologica Scandinavica 34; 400–403, 1990
Krane BD, Kreutz JM, Johnson DL, Mazuzan JE. Alfentanil and delayed respiratory depression: case studies and review. Anesthesia and Analgesia 70: 557–561, 1990
Langley MS, Heel RC. Propofol: a review of its pharmacodynamic and pharmacokinetic properties and use as ah intravenous anaesthetic. Drugs 35: 334–372, 1988
Larsen R, Rathgeber J, Bagdahn A, Lange H, Rieke H. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients: a comparison with etomidate. Anaesthesia 43 (Suppl.): 25–31, 1988
Lichtor JL, Apfelbaum JL, Lane B, Coalson D, Uitvlugt A, et al. Long-term recovery: desflurane vs propofol. Abstract. Anesthesia and Analgesia 72: S163, 1991
Lowenstein E, Hallowell P, Levine FH, Daggett WM, Austen GA, et al. Cardiovascular response to large doses of intravenous morphine in man. New England Journal of Medicine 281: 1389–1393, 1969
Lunn JK, Stanley TH, Eisel JH, Webster L, Woodward A. High-dose fentanyl anesthesia for coronary artery surgery: plasma fentanyl concentrations and influence of nitrous oxide on cardiovascular responses. Anesthesia and Analgesia: Current Researches 58: 390–395, 1979
Merkel G, Eger II EI. A comparative study of halothane and halopropane anesthesia: including method for determining equipotency. Anesthesiology 24: 346–357, 1963
Millar JM, Jewkes CF. Recovery and morbidity after daycase anaesthesia: a comparison of propofol with thiopentone-enflurane with and without alfentanil. Anaesthesia 43: 738–741, 1988
Monk CR, Coates DP, Prys-Roberts C, Turtle MJ, Spelina K. Haemodynamic effects of a prolonged infusion of propofol as a supplement to nitrous oxide anaesthesia. British Journal of Anaesthesia 59: 954–960, 1987
Moore RA, Allen MC, Wood PJ, Rees LH, Sear JW. Perioperative endocrine effects of etomidate. Anaesthesia 40: 124–130, 1985
Mulier JP, Wouters PF, Van Aken H, Vermaut G, Vandermeersch E. Cardiodynamic effects of propofol in comparison with thiopental: assessment with a transesophageal echocardiographic approach. Anesthesia and Analgesia 72: 28–35, 1991
Neuberger JM. Halothane and hepatitis: incidence, predisposing factors and exposure guidelines. Drug Safety 5: 28–38, 1990
Nilsson A, Persson MP, Hartvig P. Effects of the benzodiazepine antagonist flumazenil on postoperative performance following total intravenous anaesthesia with midazolam and alfentanil. Acta Anaesthesiologica Scandinavica 32: 441–446, 1988
Nilsson A, Tamsen A, Persson P. Midazolam-fentanyl anaesthesia for major surgery: plasma levels of midazolam during prolonged total intravenous anaesthesia. Acta Anaesthesiologica Scandinavica 30: 66–69, 1986
Peacock JE, Lewis RP, Reilly CS, Nimmo WS. Effect of different rates of infusion of propofol for induction of anaesthesia in eldery patients. British Journal of Anaesthesia 65: 346–352, 1990
Philbin DM, Rosow CE, Schneider RC, Koski G, D’Ambra MN. Fentanyl and sufentanil anesthesia revisited: how much is enough? Anesthesiology 73: 5–11, 1990
Prys-Roberts C. Cardiovascular effects of continuous intravenous anaesthesia compared with those of inhalational anaesthesia. Acta Anaesthesiologica Scandinavica 26 (Suppl. 75): 10–17, 1982
Prys-Roberts C. Anaesthesia: a practical or impractical construct? British Journal of Anaesthesia 59: 1341–1345, 1987
Prys-Roberts C, Sear JW, Low JM, Phillips KC, Dagnino J. Hemodynamic and hepatic effects of methohexital infusion during nitrous oxide anesthesia in humans. Anesthesia and Analgesia 62: 317–323, 1983
Quasha AL, Eger II EI, Tinker JH. Determination and applications of MAC. Anesthesiology 53: 315–334, 1980
Raeder JC, Hole A, Arnulf V, Hougens Grynne B. Total intravenous anaesthesia with midazolam and flumazenil in outpatient clinics: a comparison with isoflurane or thiopentone. Acta Anaesthesiologica Scandinavica 31: 634–641, 1987
Rampil IJ, Lockhart SH, Zwass MS, Peterson N, Yasuda N, et al. Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 74: 429–433, 1991
Reiz S, Balfors E, Sorensen MB, Ariola Jr S, Friedman A, et al. Isoflurane a powerful coronary vasodilator in patients with-coronary artery disease. Anesthesiology 59: 91–97, 1983
Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam pharmacology and uses. Anesthesiology 62: 310–324, 1985
Richards MJ, Skues MA, Jarvis AP, Prys-Roberts C. Total I.V. anaesthesia with propofol and alfentanil: dose requirements for propofol and the effect of premedication with clonidine. British Journal of Anaesthesia 65: 157–163, 1990
Roberts FL, Dixon J, Lewis GTR, Tackley RM, Prys-Roberts C. Induction and maintenance of propofol anaesthesia: a manual infusion scheme. Anaesthesia 43 (Suppl.): 14–17, 1988
Robinson D. Respiratory arrest after recovery from anaesthesia supplemented with sufentanil. Canadian Journal of Anaesthesia 35: 101–102, 1988
Roizen MF, Horrigan RW, Frazer BM. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision — MAC BAR. Anesthesiology 54: 390–398, 1981
Rydvall A, Haggmark S, Nyhman H, Reiz S. Effects of enflurane on coronary haemodynamics in patients with ischaemic heart disease. Acta Anaesthesiologica Scandinavica 28: 690–695, 1984
Salmenpera M, Peltola K, Takkunen O, Heinonen J. Cardiovascular effects of pancuronium and vecuronium during high-dose fentanyl anesthesia. Anesthesia and Analgesia 62: 1059–1064, 1983
Schuttler J, Kloos S, Schwilden H, Stoeckel H. Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion. Anaesthesia 43 (Suppl.): 2–7, 1988
Sear JW, Phillips KC, Andrews CJH, Prys-Roberts C. Dose response relationships for infusions of Althesin or methohexitone. Anaesthesia 38: 931–936, 1983
Sear JW, Prys-Roberts C, Phillips KC. Age influences the minimum infusion rate (ED50) for continuous infusions of Althesin and methohexitone. European Journal of Anaesthesiology 1: 319–325, 1984
Sear JW, Shaw I, Wolf A, Kay NH. Infusion of propofol to supplement nitrous oxide-oxygen for maintenance of anaesthesia: a comparison with halothane. Anaesthesia 43 (Suppl): 18–22, 1988
Shafer A, Doze VA, Shafer SL, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 69: 348–356, 1988
Skues MA, Richards MJ, Jarvis AP, Prys-Roberts C. Preinduction atropine or glycopyrrolate and hemodynamic changes associated with induction and maintenance of anesthesia with propofol and alfentanil. Anesthesia and Analgesia 69: 386–390, 1989
Slogoff S, Keats A. Randomized trial of primary anesthetic agents on outcome of coronary bypass operations. Anesthesiology 70: 179–188, 1989
Smiley RM, Ornstein E, Matteo RS, Pantuck CB. Desflurane and isoflurane in surgical patients: comparison of emergence time. Anesthesiology 74: 425–428, 1991
Smith G. Halothane in clinical practice. British Journal of Anaesthesia 53: 17s–25s, 1981
Spelina KR, Coates DP, Monk CR, Prys-Roberts C, Norley I, et al. Dose requirements of propofol by infusion during nitrous oxide anaesthesia in man. I. Patients premedicated with morphine. British Journal of Anaesthesia 58: 1080–1084, 1986
Stephan H, Sonntag H, Schenk HD, Kettler D, Khambatta HJ. Effects of propofol on cardiovascular dynamics, myocardial blood flow, and myocardial metabolism in patients with coronary artery disease. British Journal of Anaesthesia 58: 969–975, 1986
Stevens WC, Cromwell TH, Halsey MJ, Eger EI, Shakespear TF, et al. The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant carbon dioxide tension. Anesthesiology 35: 8–16, 1971
Stoeckel H, Hengstmann JH, Schuttler J. Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression. British Journal of Anaesthesia 51: 741–744, 1979
Strum DP, Eger II EI. Partition coefficients for sevoflurane in human blood, saline and olive oil. Anesthesia and Analgesia 66; 654–656, 1987
Toriumi K, Tanifuji Y, Yasuda N, Kobayashi K. Effect of prolonged anesthesia with sevoflurane vs isoflurane on serum fluoride in surgical patients. Abstract. Anesthesia and Analgesia 72; S298, 1991
Tsai SK, Lee C, Kwan W-F, Chen B-J, Cantley E. Cognitive recovery from 0.65 MAC desflurane or isoflurane anesthesia with 60% nitrous oxide. Abstract. Anesthesia and Analgesia 72: S299, 1991
Tuman K, McCarthy R, Spiess B, Davalle M, Dabir R, et al. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 70: 189–198, 19
Turtle MJ, Cullen P, Prys-Roberts C, Coates D, Monk CR, et al. Dose requirements of propofol by infusion during nitrous oxide anaesthesia in man. II. Patients premedicated with lorazepam. British Journal of Anaesthesia 59: 283–287, 1987
Van Aken H, Meinshausen E, Prien T, Brussel T, Heinecke A, et al. The influence of fentanyl and tracheal intubation on the hemodynamic effects of anesthesia induction with propofol/ N2O in humans. Anesthesiology 68: 157–163, 1988
Vuyk J, Hennis PJ, Burm AGL, de Voogt J-WH, Spierdijk J. Comparison of midazolam and propofol in combination with alfentanil for total intravenous anaesthesia. Anesthesia and Analgesia 71; 645–650, 1990
Wall RJ, Zacharias M. Effects of alfentanil on induction and recovery from propofol anaesthesia in day surgery. Anaesthesia and Intensive Care 18: 214–218, 1990
Weiskopf RB, Eger II EI, Holmes MA, Yasuda N, Johnson BH, et al. Cardiovascular actions of common anesthetic adjuvants during desflurane (I-653) and isoflurane anesthesia in swine. Anesthesia and Analgesia 71: 144–148, 1990
White PF, Dworsky WA, Horai Y, Trevor AJ. Comparison of continuous infusion of fentanyl or ketamine versus thiopental: determining the mean effective serum concentrations for outpatient anesthesia. Anesthesiology 59: 564–569, 1983
White PF, Way WL, Trevor AJ. Ketamine: its pharmacology and therapeutivc uses. Anesthesiology 56: 119–136, 1982
Wilson E, David A, Mackenzie N, Grant IS. Sedation during spinal anaesthesia: comparison of propofol and midazolam. British Journal of Anaesthesia 64: 48–52, 1990
Wynands JE, Wong P, Townsend GE, Sprigge JS, Whalley DG. Narcotic requirements for intravenous anesthesia. Anesthesia and Analgesia 63: 101–105, 1984
Yasuda N, Lockhart SH, Eger II EI, Weiskopf RB, Johnson BH, et al. Kinetics of desflurane, isoflurane and halothane in humans. Anesthesiology 74: 489–490, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sear, J.W. Practical Treatment Recommendations for the Safe Use of Anaesthetics. Drugs 43, 54–68 (1992). https://doi.org/10.2165/00003495-199243010-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199243010-00006